2020
DOI: 10.1002/jso.26259
|View full text |Cite
|
Sign up to set email alerts
|

Actual 10‐year survivors and 10‐year recurrence free survivors after primary liver resection for hepatocellular carcinoma in the 21st century: A single institution contemporary experience

Abstract: Background: At present, the majority of outcome studies of survival of hepatocellular carcinoma (HCC) post-liver resection (post-LR) present actuarial survival data, which often results in overestimation of survival. We sought to evaluate the actual 10-year survival post-LR for HCC and identify variables that are associated with long-term survival. Methods: We performed a retrospective review of 600 consecutive patients who underwent primary LR for HCC from 2000 to 2010 at our institution. Twenty-eight patient… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 25 publications
(90 reference statements)
0
8
0
Order By: Relevance
“…The most prevalent type of liver cancer is Hepatocellular carcinoma (HCC) or hepatoma with a median survival time of fewer than six months if untreated, and a five-year survival rate of only 5–9% from the time of diagnosis [ 11 , 12 ]. Since HCC is the sixth most common cancer and the second most common cause of cancer mortality worldwide, establishing an efficient treatment for this type of cancer has never been more urgent [ 13 , 14 , 15 , 16 , 17 , 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…The most prevalent type of liver cancer is Hepatocellular carcinoma (HCC) or hepatoma with a median survival time of fewer than six months if untreated, and a five-year survival rate of only 5–9% from the time of diagnosis [ 11 , 12 ]. Since HCC is the sixth most common cancer and the second most common cause of cancer mortality worldwide, establishing an efficient treatment for this type of cancer has never been more urgent [ 13 , 14 , 15 , 16 , 17 , 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…These findings are consistent with that reported in the literature. The patient clinicopathological features in this study were typical of the demographics of patients with HCC in the region, with patients being predominantly male and of hepatitis B aetiology [21,22]. While most of our patients had peritoneal metastasis followed by adrenal and bowel metastasis, more data exist in the literature on adrenal metastasis followed by peritoneal metastasis.…”
Section: Discussionmentioning
confidence: 63%
“…Treatment options, including hepatectomy, local ablation therapy, transcatheter arterial chemoembolization (TACE), systemic therapy, and liver transplantation, are selected based on tumor condition and liver functional reserve 3–6 . Hepatectomy is considered the treatment of choice in patients with early stage HCC without liver cirrhosis 7–9 . Although the management of HCC has substantially improved over the past decade, the prognosis remains poor because of tumor invasiveness, intrahepatic and extrahepatic metastases, and high rate of recurrence after curative resection 10–14 …”
Section: Introductionmentioning
confidence: 99%